FDA NDAC MEMBERS TONG, SLINGLUFF CONFIRMED, EFFECTIVE SEPT. 4,
This article was originally published in The Tan Sheet
Executive Summary
FDA NDAC MEMBERS TONG, SLINGLUFF CONFIRMED, EFFECTIVE SEPT. 4, in time for the two new appointees to sit on the analgesic indications subcommittee, which is comprised of all Nonprescription Drugs Advisory Committee members and two members from the Arthritis Advisory Committee. The subcommittee is scheduled to meet Sept. 8-9. The two new members are Theodore Tong, PharmD, University of Arizona and Beth Slingluff, Carondelet St. Mary's Hospital, Tucson, Ariz. ("The Tan Sheet" Aug. 1, In Brief).